Unraveling CIDP: Exploring the Role of Complement in Axonal Integrity
Chronic inflammatory demyelinating polyneuropathy (CIDP) presents complex pathophysiological mechanisms that warrant deeper exploration. Our symposium will examine the critical relationship between complement activation and axonal health in the peripheral nervous system and explore ongoing research aiming to enhance our knowledge of this disease.
Claudia Sommer, MD
(Chair)
Jan Lünemann, MD, MBA
Jeffrey Allen, MD
Symposium Slides
Symposium Recording
*This Symposium is intended for medical and scientific exchange purposes with health care professionals and patient advocacy group leadership only. This program is non-promotional, is sponsored by Sanofi Medical, and the content contained in this presentation was developed by Sanofi Medical in collaboration with the speakers. The speakers were compensated by Sanofi in connection with this presentation. This presentation is not eligible for CME. This Symposium discusses treatment agents that are investigational and no conclusions regarding safety and efficacy should be drawn. For approved agents referenced in this Symposium, please refer to the prescribing information available in your country.